Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics

1.50 hr(s) | CME , MOC , ABIM

Specialty: AML

Therapeutic Area(s): Hematology , Oncology

Release Date: June 15, 2021

Expiration Date: June 15, 2021

Location: Live Webcast

The increasing availability and use of novel therapeutics has eclipsed the once-standard and widespread use of conventional chemotherapy for patients with acute myeloid leukemia (AML). The growing arsenal of innovative agents—which now includes newer cytotoxic formulations, epigenetic and targeted agents, and novel antibodies—has also afforded clinicians the opportunity to develop treatment protocols designed to address unmet medical needs in many different AML populations.

Access this activity
Share via
Copy link
Powered by Social Snap